Northeast Financial Consultants »

Immunome shares owned by Northeast Financial Consultants

Quarter-by-quarter ownership of Immunome (IMNM) shares owned by Northeast Financial Consultants from 13F filings

Historical chart of Northeast Financial Consultants investment in Immunome

Tip: Access up to 7 years of quarterly data

All positions including Immunome held by Northeast Financial Consultants consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunome by Northeast Financial Consultants

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.1M 73k 14.62
2024-06-30 $883k 73k 12.10

More positions owned by Northeast Financial Consultants

Vanguard Index Fds Growth Etf (VUG)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Specialized Funds Div App Etf (VIG)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core Div Grwth (DGRO)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple (AAPL)
Blackstone Secd Lending Common Stock (BXSL)
Microsoft Corporation (MSFT)
Vanguard Whitehall Fds High Div Yld (VYM)
Amazon (AMZN)
Pacer Fds Tr Us Cash Cows 100 (COWZ)
Golub Capital BDC (GBDC)
JPMorgan Chase & Co. (JPM)
Pfizer (PFE)

View all positions for Northeast Financial Consultants

Top funds holding Immunome

T. Rowe Price Investment Management
Redmile Group
BlackRock
EcoR1 Capital
BlackRock
Henderson Group
Vanguard Group
State Street Corporation
T. Rowe Price Associates
Marshall Wace
Opaleye Management
Geode Capital Management
Woodline Partners
Avidity Partners Management
Victory Capital Management

View all funds holding Immunome